Contact
searchSearch
HMP Global

Volume 27 - Issue 6 - June, 2015

Feature

Original Contribution
Systematic Review of the BridgePoint System for Crossing Coronary and Peripheral Chronic Total Occlusions
05/29/2015
Subhash Banerjee, MD, FSCAI; Deborah Shorrock; Spyros Maragkoydakis, MD; Michele Roesle, RN, BSN, MD; Bavana V. Rangan, BDS, MPH, MD; Anna P. Kotsia, MD, PhD; Georgios Christopoulos, MD; Shuaib M. Abdullah, MD; Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI; Jedrek Wosik, MD
The authors performed a systematic review of the literature on the BridgePoint system published between October 2008 and August 2014 and found the system to be associated with high procedural success rates and low complication rates when used...
The authors performed a systematic review of the literature on the BridgePoint system published between October 2008 and August 2014 and found the system to be associated with high procedural success rates and low complication rates when used...
The authors performed a...
05/29/2015
Journal of Invasive Cardiology
Original Contribution
Clinical Impact of Second-Generation Everolimus-Eluting Stents Compared With First-Generation Drug-Eluting Stents in Diabetic Patients Undergoing Multivessel Percutaneous Coronary Intervention
05/29/2015
Lakshmana Pendyala, MD; Joshua Loh, MD; William O. Suddath, MD; Hironori Kitabata, MD; Rebecca L. Torguson, BS, MPH; Sa'ar Minha, MD; Fang Chen, PhD; Ron Waksman, MD; Lowell F. Satler, MD; Augusto D. Pichard, MD, FACC, FSCAI
This study aimed to evaluate the safety and efficacy of everolimus-eluting stent (EES) use compared with first-generation drug-eluting stent (DES) use in diabetic patients undergoing multivessel percutaneous coronary intervention. In diabetic...
This study aimed to evaluate the safety and efficacy of everolimus-eluting stent (EES) use compared with first-generation drug-eluting stent (DES) use in diabetic patients undergoing multivessel percutaneous coronary intervention. In diabetic...
This study aimed to evaluate the...
05/29/2015
Journal of Invasive Cardiology
Review
Utility of Transradial Approach for Peripheral Vascular Interventions
05/29/2015
Kintur Sanghvi, MD, FACC, FSCAI; Tejas M. Patel, MD, DM; Rajiv Gulati, MD, PhD; Sanjay C. Shah, MD, DM; John T. Coppola, MD, FACC, FSCAI; Samir B. Pancholy, MD, FACP, FACC, FSCAI; Surender Deora, MD, DM
This review demonstrates the feasibility of the transradial approach (TRA) to address different peripheral vascular lesions. Advantages and limitations are highlighted, and the results of different studies using this approach for peripheral...
This review demonstrates the feasibility of the transradial approach (TRA) to address different peripheral vascular lesions. Advantages and limitations are highlighted, and the results of different studies using this approach for peripheral...
This review demonstrates the...
05/29/2015
Journal of Invasive Cardiology
Original Contribution
Percutaneous Paravalvular Leak Closure for Balloon-Expandable Transcatheter Aortic Valve Replacement: A Comparison With Surgical Aortic Valve Replacement Paravalvular Leak Closure
05/29/2015
Kazuaki Okuyama, MD; Mohammad Kashif, MD; Hasan Jilaihawi, MBChB, MD; Vikas Soni, MD; Raj R. Makkar, MD; Takashi Matsumoto, MD; Wen-Loong Yeow, MD; Mamoo Nakamura, MD; Saibal Kar, MD; Wen Cheng, MD
Paravalvular leak is frequently observed after transcatheter aortic valve replacement (TAVR) and is related to increased mortality. Percutaneous PVL closure has been performed following surgical aortic valve replacement (SAVR); however, the...
Paravalvular leak is frequently observed after transcatheter aortic valve replacement (TAVR) and is related to increased mortality. Percutaneous PVL closure has been performed following surgical aortic valve replacement (SAVR); however, the...
Paravalvular leak is frequently...
05/29/2015
Journal of Invasive Cardiology
Original Contribution
A Comparative Study of Defibrillator Leads at a Large-Volume Implanting Hospital: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS")
05/29/2015
Todd J. Cohen, MD, FACC, FHRS; Dhimesh P. Patel, MD; Wilbur J. Asheld, DO; Joseph J. Germano, DO; Shahidul Islam, PStat, MPH, CPH
Implantable lead survival has been the subject of many multicenter studies over the past decade. The purpose of this study was to examine survival in the implantable defibrillator subset of implanted leads at a large-volume implanting...
Implantable lead survival has been the subject of many multicenter studies over the past decade. The purpose of this study was to examine survival in the implantable defibrillator subset of implanted leads at a large-volume implanting...
Implantable lead survival has...
05/29/2015
Journal of Invasive Cardiology
Original Contribution
Comparison of the Effectiveness and Safety of Single Versus Dual Occluders for the Closure of Multiple Atrial Septal Defects
05/29/2015
Yajuan Du, MS; Zhi Hu, MD; Yushun Zhang, MD; Tingting Zhang, MS; Gesheng Cheng, MS; Xuegang Xie, MS; Xumei He, MS
A retrospective study to compare the effectiveness and safety of single vs dual occluders in the treatment of multiple atrial septal defects. 
A retrospective study to compare the effectiveness and safety of single vs dual occluders in the treatment of multiple atrial septal defects. 
A retrospective study to compare...
05/29/2015
Journal of Invasive Cardiology
Original Contribution
Transcatheter Pulmonary Valve Implantation in Patients With Right Ventricular Outflow Tract Dysfunction: Early and Mid-Term Results
05/29/2015
Elżbieta Katarzyna Biernacka, MD, PhD; Witold Rużyłło, PhD; Marcin Demkow, PhD, MD; Mirosław Kowalski, MD, PhD; Mateusz Śpiewak, MD, PhD; Walerian Piotrowski, PhD; Mariusz Kuśmierczyk, MD, PhD; Sławomir Banaś, MD, PhD; Jacek Różanski, MD, PhD; Piotr Hoffman, PhD
Early and long-term results after TPVI in patients with full conduit or patched RV outflow tract dysfunction. 
Early and long-term results after TPVI in patients with full conduit or patched RV outflow tract dysfunction. 
Early and long-term results...
05/29/2015
Journal of Invasive Cardiology
Original Contribution
Coronary Flow Velocity Reserve in Donor Artery and Myocardial Performance Index After Successful Recanalization of Chronic Total Coronary Occlusions
05/29/2015
Mustafa Gür, MD; Taner Seker, MD; Caner Turkoglu, MD; Gülhan Yüksel Kalkan, MD; Durmuş Yıldıray Şahin, MD; Murat Çaylı, MD; Ahmet Oytun Baykan, MD; Durmus Shahin, MD; Zafer Elbasan, MD
This study used non-invasive coronary flow velocity reserve to evaluate whether the blood flow of donor artery reverts to normal after CTO-PCI.
This study used non-invasive coronary flow velocity reserve to evaluate whether the blood flow of donor artery reverts to normal after CTO-PCI.
This study used non-invasive...
05/29/2015
Journal of Invasive Cardiology

Department

Letters to the Editor
Incidence and Predictors of Radial Artery Occlusion
05/29/2015
Ahmet Avci, MD; Kenan Demir, MD; Abdullah Tunez, MD
The authors further the discussion from a recently published article, and focus on the role of anticoagulation and its importance in the prevention of radial artery occlusion. 
The authors further the discussion from a recently published article, and focus on the role of anticoagulation and its importance in the prevention of radial artery occlusion. 
The authors further the...
05/29/2015
Journal of Invasive Cardiology
Letters to the Editor
Radial Artery Occlusion: Size and More – How Small is Too Small?
05/29/2015
Yashasvi Chugh, MD; Sanjay Chugh, MD, DM
The authors comment on a recently published article on radial artery occlusions, and discuss whether the study results are applicable to all patient populations.
The authors comment on a recently published article on radial artery occlusions, and discuss whether the study results are applicable to all patient populations.
The authors comment on a...
05/29/2015
Journal of Invasive Cardiology

News

Intravascular Imaging
ECLIPSE Trial: Intravascular Imaging Can Improve Outcomes for Complex Stenting Procedures in Patients with High-Risk Calcified CAD
03/31/2025
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that...
03/31/2025
Cath Lab Digest
Aortic Stenosis
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
03/31/2025
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the...
03/31/2025
Cath Lab Digest
CAD in Women
New Intermountain Health Study Finds Gap Between Heart Disease Outcomes in Men and Women Has Narrowed Over Past 20 Years  
03/31/2025
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older...
03/31/2025
Cath Lab Digest
AI
HeartFocus Clinical Trial Proves AI Can Empower Novices to Deliver Diagnostic-Quality Cardiac Ultrasounds
03/31/2025
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of...
03/31/2025
Cath Lab Digest
plaque analysis
CONFIRM2 Registry: Late-Breaking Clinical Trial Results Demonstrate the Predictive Power of Cleerly's AI-QCT for Women’s Cardiovascular Risk at ACC.25
03/31/2025
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that...
03/31/2025
Cath Lab Digest
Statins
CorCal Outcomes Study: Who Needs a Statin? Intermountain Study Compares Prescribing Recommendations Based on Traditional Risk Factors vs. Coronary Artery Calcium Scoring
03/31/2025
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal...
03/31/2025
Cath Lab Digest
CardiAMP Procedure
Cell Therapy
BioCardia Phase 3 CARDIAMP-HF Trial of Novel Cardiac Cell Therapy for Ischemic Heart Failure Shows Increased Survival, Decreased Cardiac Events, and Improved Quality of Life at Two Years
03/31/2025
"In this rigorous CardiAMP-HF Trial, patients who received the novel cell therapy adjunctive to medication experienced decreased mortality and MACCE, with improved quality of life, when compared to those on medication alone," said...
"In this rigorous CardiAMP-HF Trial, patients who received the novel cell therapy adjunctive to medication experienced decreased mortality and MACCE, with improved quality of life, when compared to those on medication alone," said...
"In this rigorous CardiAMP-HF...
03/31/2025
Cath Lab Digest
Peripheral Arterial Disease
New Study Finds Peripheral Artery Disease Often Underdiagnosed and Undertreated; Opportunity to Improve Treatments and Lower Death Rates
03/31/2025
Researchers identified 7,522 patients who had a symptomatic peripheral artery disease diagnosis at Intermountain Health facilities between January 2006 and December 2021 and were seen once in follow-up within at least 18 months of their...
Researchers identified 7,522 patients who had a symptomatic peripheral artery disease diagnosis at Intermountain Health facilities between January 2006 and December 2021 and were seen once in follow-up within at least 18 months of their...
Researchers identified 7,522...
03/31/2025
Cath Lab Digest
TAVR
Evolut Low Risk Trial: Medtronic Evolut TAVR System Shows Durable Clinical Outcomes and Outstanding Valve Performance at 5 Years in Low-Risk AS Patients
03/31/2025
"Results at five years support Evolut's supra-annular, self-expanding TAVR as a safe, effective, and durable alternative to surgery for patients with severe aortic stenosis, regardless of their surgical risk," said Michael J. Reardon, MD.
"Results at five years support Evolut's supra-annular, self-expanding TAVR as a safe, effective, and durable alternative to surgery for patients with severe aortic stenosis, regardless of their surgical risk," said Michael J. Reardon, MD.
"Results at five years support...
03/31/2025
Cath Lab Digest
Calcium Score
Low Coronary Artery Calcium Score is Associated with An Excellent Prognosis Regardless of a Person’s Age, New Intermountain Health Study Finds
03/31/2025
“We found that a zero-plaque burden is not only highly prognostic of good heart health at any age, but also of excellent overall survival,” said Jeffrey L. Anderson, MD, principal investigator of the study.
“We found that a zero-plaque burden is not only highly prognostic of good heart health at any age, but also of excellent overall survival,” said Jeffrey L. Anderson, MD, principal investigator of the study.
“We found that a zero-plaque...
03/31/2025
Cath Lab Digest

CRT Conference Coverage
Disparities in Interventional Cardiology
04/02/2025
Laura Simson
At the Sunday afternoon "Disparities in Interventional Cardiology" session at CRT 2025, experts presented compelling data and discussed the barriers that limit diverse representation in the field, ranging from clinical trials and...
At the Sunday afternoon "Disparities in Interventional Cardiology" session at CRT 2025, experts presented compelling data and discussed the barriers that limit diverse representation in the field, ranging from clinical trials and...
At the Sunday afternoon...
04/02/2025
Journal of Invasive Cardiology
CRT Conference Coverage
Artificial Intelligence in Coronary Artery Disease Diagnosis and Intervention
04/02/2025
Laura Simson
In his Sunday morning session and ensuing panel discussion at CRT 2025, Dr Ran Kornowski of the Rabin Medical Center in Petach-Tikva, Israel, detailed how AI is transforming clinical practice and research in interventional cardiology.
In his Sunday morning session and ensuing panel discussion at CRT 2025, Dr Ran Kornowski of the Rabin Medical Center in Petach-Tikva, Israel, detailed how AI is transforming clinical practice and research in interventional cardiology.
In his Sunday morning session...
04/02/2025
Journal of Invasive Cardiology
Original Contribution
Polidocanol Ablation in Midventricular Obstructive Cardiomyopathy: Novel Approach and Early Outcomes
04/01/2025
Limited data exist regarding polidocanol use for septal ablation, particularly in the context of midventricular obstruction (MVO) . This study presents the first reported use of polidocanol for septal ablation in patients with MVO.
Limited data exist regarding polidocanol use for septal ablation, particularly in the context of midventricular obstruction (MVO) . This study presents the first reported use of polidocanol for septal ablation in patients with MVO.
Limited data exist regarding...
04/01/2025
Journal of Invasive Cardiology
Original Contribution
Heart Rate Variability of Interventional Cardiology Fellows and Attendings and Changes Over Time
04/01/2025
The study examined the stress levels of interventional cardiology (IC) fellows and attendings using both objective (heart rate variability) and subjective (State Trait Anxiety Inventory) metrics across the IC fellowship.
The study examined the stress levels of interventional cardiology (IC) fellows and attendings using both objective (heart rate variability) and subjective (State Trait Anxiety Inventory) metrics across the IC fellowship.
The study examined the stress...
04/01/2025
Journal of Invasive Cardiology
Intravascular Imaging
ECLIPSE Trial: Intravascular Imaging Can Improve Outcomes for Complex Stenting Procedures in Patients with High-Risk Calcified CAD
03/31/2025
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that...
03/31/2025
Cath Lab Digest
Aortic Stenosis
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
03/31/2025
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the...
03/31/2025
Cath Lab Digest
CAD in Women
New Intermountain Health Study Finds Gap Between Heart Disease Outcomes in Men and Women Has Narrowed Over Past 20 Years  
03/31/2025
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older...
03/31/2025
Cath Lab Digest
AI
HeartFocus Clinical Trial Proves AI Can Empower Novices to Deliver Diagnostic-Quality Cardiac Ultrasounds
03/31/2025
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of...
03/31/2025
Cath Lab Digest
plaque analysis
CONFIRM2 Registry: Late-Breaking Clinical Trial Results Demonstrate the Predictive Power of Cleerly's AI-QCT for Women’s Cardiovascular Risk at ACC.25
03/31/2025
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that...
03/31/2025
Cath Lab Digest
Statins
CorCal Outcomes Study: Who Needs a Statin? Intermountain Study Compares Prescribing Recommendations Based on Traditional Risk Factors vs. Coronary Artery Calcium Scoring
03/31/2025
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal...
03/31/2025
Cath Lab Digest

June 2015 Volume 27 Issue 6

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use